Teva Pharmaceutical Industries shares owned by Weiss Multi-strategy Advisers
Quarter-by-quarter ownership of Teva Pharmaceutical Industries (TEVA) shares owned by Weiss Multi-strategy Advisers
from 13F filings
Historical chart of Weiss Multi-strategy Advisers investment in Teva Pharmaceutical Industries
Tip: Access up to 7 years of quarterly data
All positions including Teva Pharmaceutical Industries held by Weiss Multi-strategy Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Teva Pharmaceutical Industries by Weiss Multi-strategy Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $5.3M | 504k | 10.44 |
| 2023-09-30 | $3.8M | 376k | 10.20 |
| 2023-06-30 | $2.5M | 334k | 7.53 |
| 2023-03-31 | $1.5M | 170k | 8.85 |
| 2022-12-31 | $3.7M | 409k | 9.12 |
| 2022-09-30 | $2.0M | 252k | 8.07 |
| 2022-06-30 | $2.3M | 301k | 7.52 |
| 2022-03-31 | $393k | 42k | 9.40 |
| 2019-03-31 | $314k | 20k | 15.70 |
| 2016-09-30 | $345k | 7.5k | 46.00 |
| 2016-06-30 | $366k | 7.3k | 50.21 |
| 2016-03-31 | $562k | 11k | 53.52 |
| 2015-12-31 | $715k | 11k | 65.60 |
| 2015-09-30 | $627k | 11k | 56.49 |
| 2015-06-30 | $4.7M | 80k | 59.10 |
| 2015-03-31 | $7.2M | 115k | 62.30 |
| 2014-12-31 | $7.2M | 125k | 57.51 |
| 2014-09-30 | $7.5M | 140k | 53.75 |
| 2014-06-30 | $7.3M | 140k | 52.42 |
| 2014-03-31 | $7.4M | 140k | 52.84 |
| 2013-12-31 | $5.8M | 145k | 40.08 |
| 2013-09-30 | $4.2M | 110k | 37.78 |
| 2013-06-30 | $2.7M | 70k | 39.20 |
| 2013-03-31 | $2.0M | 50k | 39.68 |
| 2012-12-31 | $3.4M | 90k | 37.35 |
| 2012-09-30 | $3.3M | 80k | 41.41 |
| 2012-06-30 | $2.8M | 70k | 39.44 |
| 2012-03-31 | $1.8M | 40k | 45.05 |
| 2011-12-31 | $5.7M | 140k | 40.36 |
| 2011-09-30 | $6.5M | 175k | 37.22 |
| 2011-06-30 | $7.7M | 160k | 48.22 |
| 2011-03-31 | $5.5M | 110k | 50.17 |
More positions owned by Weiss Multi-strategy Advisers
View all positions for Weiss Multi-strategy Advisers
Top funds holding Teva Pharmaceutical Industries
View all funds holding Teva Pharmaceutical Industries